MDR1-P-glycoprotein behaves as an oncofetal protein that promotes cell survival in gastric cancer cells

Laboratory Investigation

Volumn 92, Issue 10, 2012, Pages 1407-1418

  Rocco, Alba ^a   Compare, Debora ^a   Liguori, Eleonora ^a   Cianflone, Alessandra ^a   Pirozzi, Giuseppe ^b   Tirino, Virginia ^b   Bertoni, Alessandra ^a   Santoriello, Margherita ^a   Garbi, Corrado ^a   D'Armiento, Maria ^a   Staibano, Stefania ^a   Nardone, Gerardo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

apoptosis; gastric carcinogenesis; H. pylori; P glycoprotein; stomach morphogenesis

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN; ONCOFETAL ANTIGEN; PROTEIN BCL XL; SMALL INTERFERING RNA;

ADULT; AGED; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL MEMBRANE; CELL STRESS; CELL SURVIVAL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FEMALE; FETUS; GASTRITIS; GENE; GENE LOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INTESTINE METAPLASIA; MALE; MITOCHONDRION; MULTIDRUG RESISTANCE PROTEIN 1 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; STOMACH CANCER; WESTERN BLOTTING;

EID: 84866862182     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2012.100     Document Type: Article

References (39)

1. Li Y, Yuan H, Yang K, et al. The structure and functions of P-glycoprotein. Curr Med Chem 2010;17:786-800.
2. Mizutani T, Masuda M, Nakai E, et al. Genuine functions of P-glycoprotein (ABCB1). Curr Drug Metab 2008;9:167-174.
3. Goda K, Bacsó Z, Szabó G. Multidrug resistance through the spectacle of P-glycoprotein. Curr Cancer Drug Targets 2009;9:281-297.
4. Wang B, Li XQ, Ma X, et al. Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type. Am J Hematol 2008;83: 795-799.
5. Mouly S, Paine MF. P-glycoprotein increases from proximal to distal regions of human small intestine. Pharm Res 2003;20:1595-1599.
6. Zhang D, Fan D. Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges. Expert Rev Anticancer Ther 2007;7:1369-1378.
7. Xu HW, Xu L, Hao JH, et al. Expression of P-glycoprotein and multidrug resistance-associated protein is associated with multidrug resistance in gastric cancer. J Int Med Res 2010;38:34-42.
8. Nardone G, Rocco A, Vaira D, et al. Expression of COX-2, mPGEsynthase1, MDR-1 (P-gp), and Bcl-xL: a molecular pathway of H pylorirelated gastric carcinogenesis. J Pathol 2004;202:305-312.
9. Chipuk JE, Fisher JC, Dillon CP, et al. Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins. Proc Natl Acad Sci USA 2008;105:20327-20332.
10. Tainton KM, Smyth MJ, Jackson JT, et al. Mutational analysis of P-glycoprotein: suppression of caspase activation in the absence of ATP-dependent drug efflux. Cell Death Differ 2004;11: 1028-1037.
11. Mantovani I, Cappellini A, Tazzari PL, et al. Caspase-dependent cleavage of 170-kDa Pglycoprotein during apoptosis of human T-lymphoblastoid CEM cells. J Cell Physiol 2006;207:836-844.
12. Guenova ML, Balatzenko GN, Nikolova VR, et al. An anti-apoptotic pattern correlates with multidrug resistance in acute myeloidleukemia patients: a comparative study of active caspase-3, cleaved PARPs, Bcl-2, Survivin and MDR1 gene. Hematology 2010;15:135-143.
13. Takanishi K, Miyazaki M, Ohtsuka M, et al. Inverse relationship between P-glycoprotein expression and its proliferative activity in hepatocellular carcinoma. Oncology 1997;54:231-237.
14. Potocnik U, Glavac D, Dean M. Common germline MDR1/ABCB1 functional polymorphisms and haplotypes modify susceptibility to colorectal cancers with high microsatellite instability. Cancer Genet Cytogenet 2008;183:28-34.
15. Van Brussel JP, Jan Van Steenbrugge G, Van Krimpen C, et al. Expression of multidrug resistance-related proteins and proliferative activity is increased in advanced clinical prostate cancer. J Urol 2001; 165:130-135.
16. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100: 57-70.
17. Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell 2004;116:205-219.
18. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. Am J Surg Pathol 1996;20:1161-1181.
19. Jass JR, Filipe MI. The mucin profiles of normal gastric mucosa, intestinal metaplasia and its variants and gastric carcinoma. Histochem J 1981;13:931-939.
20. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma. Acta Path Microbiol Scand 1965;64:31-49.
21. Ottini L, Falchetti M, Saieva C, et al. MRE11 expression is impaired in gastric cancer with microsatellite instability. Carcinogenesis 2004;25:2337-2343.
22. Garcia-Manero G, Daniel J, Smith TL, et al. DNA methylation of multiple promoter associated CpG islands in adult acute lymphocytic leukemia. Clin Cancer Res 2002;8:2217-2224.
23. van Rijnsoever M, Grieu F, Elsaleh H, et al. Characterization of colorectal cancers showing hypermethylation at multiple CpG islands. Gut 2002;51:797-802.
24. Hu M, Shivdasani RA. Overlapping gene expression in fetal mouse intestine development and human colorectal cancer. Cancer Res 2005;65:8715-8722.
25. Lum L, Beachy PA. The Hedgehog response network: sensors, switches, and routers. Science 2004;304:1755-1759.
26. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004;10:789-799.
27. Liu F, Liu S, He S, et al. Survivin transcription is associated with Pglycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells. Oncol Rep 2010;23:1469-1475.
28. van Kalken CK, Giaccone G, van der Valk P, et al. Multidrug resistance gene (P-glycoprotein) expression in the human fetus. Am J Pathol 1992;141:1063-1072.
29. Ménard D, Arsenault P. Cell proliferation in developing human stomach. Anat Embryol (Berl) 1990;182:509-516.
30. The EUROGAST Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993;341: 1359-1362.
31. Nardone G, Rocco A, Malfertheiner P. Review article: helicobacter pylori and molecular events in precancerous gastric lesions. Aliment Pharmacol Ther 2004;20:261-270.
32. Kankesan J, Vanama R, Yusuf A, et al. Effect of PSC 833, an inhibitor of P-glycoprotein on Nmethyl-N-nitrosourea induced mammary carcinogenesis in rats. Carcinogenesis 2004;25: 425-430.
33. Kankesan J, Yusuf A, Laconi E, et al. Effect of PSC 833, an inhibitor of Pglycoprotein, on 1,2-dimethylhydrazine-induced liver carcinogenesis in rats. Carcinogenesis 2003;24:1977-1984.
34. Mochida Y, Taguchi K, Taniguchi S, et al. The role of P-glycoprotein in intestinal tumorigenesis: disruption of mdr1a suppresses polyp formation in Apc(Min/+) mice. Carcinogenesis 2003;24: 1219-1224.
35. Solazzo M, Fantappiè O, Lasagna N, et al. P-g localization in mitochondria and its functional characterization in multiple drugresistant cell lines. Exp Cell Res 2006;312:4070-4078.
36. Shen Y, Chu Y, Yang Y, et al. Mitochondrial localization of P-glycoprotein in the human breast cancer cell line MCF-7/ADM and its functional characterization. Oncol Rep 2012;27: 1535-1540.
37. Ling X, He Y, Zhang G, et al. Increased P-glycoprotein expression in mitochondria is related to acquired multidrug resistance in human hepatoma cells depleted of mitochondrial DNA. Int J Oncol 2012;40:109-118.
38. Munteanu E, Verdier M, Grandjean-Forestier F, et al. Mitochondrial localization and activity of P-glycoprotein in doxorubicin-re sistant K562 cells. Biochem Pharmacol 2006;71:1162-1174.
39. Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004;305:626-629.